동물용 정형외과 임플란트 시장 : 지역별(북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카) - 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2031년)

Persistence Market Research has released an in-depth analysis examining the global Orthopedic Veterinary Implants Market. This report provides comprehensive insights into key market dynamics, including growth drivers, challenges, emerging trends, and significant developments. The study covers the period from 2024 through 2031, presenting valuable information for stakeholders to make informed decisions and develop strategic plans.

The global orthopedic veterinary implants market is anticipated to grow at a CAGR of 9% during the forecast period, with the market expected to reach a value of USD 5.3 billion by 2031, up from an estimated USD 2.9 billion in 2024.

Key Insights:

• Orthopedic Veterinary Implants Market Size (2024 Estimate): USD 2.9 Billion
• Projected Market Value (2031 Forecast): USD 5.3 Billion
• Global Market Growth Rate (CAGR 2024 to 2031): 9%

Orthopedic Veterinary Implants Market - Report Scope:

The rising pet ownership and the increasing willingness of pet owners to invest in advanced veterinary care are key drivers of the orthopedic veterinary implants market. As pet owners seek high-quality medical treatments for their animals, there is a growing demand for orthopedic implants to treat conditions like fractures, joint disorders, and degenerative diseases. Technological advancements in implant design and materials have led to more effective treatments, which is boosting the market.

Additionally, the veterinary industry's focus on providing specialized care has created a greater need for skilled orthopedic surgeons and advanced equipment, fostering the development of new products and treatment methods. Furthermore, the increase in veterinary clinics and hospitals offering orthopedic services contributes to the market's expansion.

Market Growth Drivers:

Several factors are driving the growth of the orthopedic veterinary implants market. The growing pet population and the humanization of pets are leading more pet owners to seek specialized treatments. This trend is supported by higher disposable incomes, allowing pet owners to afford more complex and expensive procedures.

Technological advancements have also played a crucial role, with innovations in implant materials like titanium and stainless steel, resulting in more durable and biocompatible products. The adoption of minimally invasive surgical techniques is gaining traction, leading to faster recovery times and reduced risks for pets. Moreover, veterinarians and pet owners are becoming more aware of the benefits of orthopedic implants, driving market growth.

Market Restraints:

Despite its growth, the orthopedic veterinary implants market faces challenges. The high cost of orthopedic procedures and implants can be prohibitive for some pet owners, limiting market reach. This is especially true in developing countries where veterinary care is less accessible, and income levels are lower. The limited availability of skilled orthopedic veterinarians is another restraint, as specialized training is required for these complex procedures. Regulatory hurdles related to product approvals and animal welfare concerns can also slow down the market's expansion. Additionally, fluctuations in raw material prices can affect the cost of manufacturing implants, impacting market dynamics.

Market Opportunities:

The orthopedic veterinary implants market offers several opportunities for growth and expansion. Companies can focus on developing cost-effective implants to cater to a broader range of customers, especially in emerging markets. The increasing adoption of pet insurance can also drive market growth by making expensive procedures more affordable for pet owners. Collaborations between veterinary schools, research institutions, and implant manufacturers can lead to the development of innovative products and techniques, fostering market growth. The rising awareness of animal welfare and the demand for high-quality veterinary care are also expected to create new opportunities for market players.

Key Questions Addressed in the Report:

• What is the Expected Value CAGR of the Orthopedic Veterinary Implants Market?
• What are the Key Factors Driving the Growth of the Orthopedic Veterinary Implants Market?
• Which Region Holds the Largest Market Share in the Orthopedic Veterinary Implants Market?
• Who are the Key Players in the Global Orthopedic Veterinary Implants Market?
• What Strategies are Adopted by Leading Companies to Sustain Growth in the Orthopedic Veterinary Implants Market?

Competitive Landscape and Business Strategies:

Leading companies in the orthopedic veterinary implants market include DePuy Synthes, BioMedtrix, VetStem Biopharma, and Veterinary Orthopedic Implants, among others. These companies focus on product innovation, quality, and strategic partnerships to maintain their competitive edge.

Strategies such as expanding distribution networks, investing in research and development, and collaborating with veterinary hospitals are commonly employed to drive growth. Companies also focus on providing comprehensive training and support to veterinary professionals to ensure successful implant outcomes.

Key Companies Profiled:

• Vet Implants
• scil animal care company GmbH
• KYON Pharma, Inc.
• Everost Inc.
• BioMedtrix, LLC
• Integra LifeSciences
• RITA LEIBINGER MEDICAL GmbH & Co. KG
• B. Braun Melsungen AG

Orthopedic Veterinary Implants Market Segmentation:

Orthopedic Veterinary Implants Market by By Product type

• Total Knee Replacement
• Total Hip Replacement
• Trauma Fixations
• Tibial Tuberosity Advancement Implants
• Tibial Plateau Leveling Osteotomy Implants
• Advanced Locking Plate System
• Total Elbow Replacement

Orthopedic Veterinary Implants Market By End User

• Veterinary Hospitals
• Veterinary Clinics

Orthopedic Veterinary Implants Market by Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa (MEA)

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Market Dynamics

• 3.1. Macro-Economic Factors
• 3.2. Drivers
  • 3.2.1. Supply Side Drivers
  • 3.2.2. Demand Side Drivers
• 3.3. Restraints
• 3.4. Opportunities
• 3.5. Trends

4. Key Inclusion

• 4.1. Arthritis in Dogs
• 4.2. Routine Care in U.S.
• 4.3. Pet Ownership

5. Global Orthopedic Veterinary Implants Market Value Analysis 2019-2023 and Forecast, 2024-2031

• 5.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 5.2. Current and Future Market Value (US$ Mn) Projections, 2024-2031
  • 5.2.1. Y-o-Y Growth Trend Analysis
  • 5.2.2. Absolute $ Opportunity Analysis

6. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Product Type

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019-2023
• 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2024-2031
  • 6.3.1. Total Knee Replacement (TKR)
  • 6.3.2. Total Hip Replacement (THR)
  • 6.3.3. Trauma Fixations
  • 6.3.4. Tibial Tuberosity Advancement (TTA) Implants
  • 6.3.5. Tibial Plateau Leveling Osteotomy (TPLO) Implants
  • 6.3.6. Advanced Locking Plate System (ALPS)
  • 6.3.7. Total Elbow Replacement (TER)
• 6.4. Market Attractiveness Analysis By Product Type

7. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by End User

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2031
  • 7.3.1. Veterinary Hospitals
  • 7.3.2. Veterinary Clinics
• 7.4. Market Attractiveness Analysis By End User

8. Global Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031, by Region

• 8.1. Introduction
• 8.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2031
  • 8.3.1. North America
  • 8.3.2. Latin America
  • 8.3.3. Europe
  • 8.3.4. Asia-Pacific
  • 8.3.5. Middle East & Africa
• 8.4. Market Attractiveness Analysis By Region

9. North America Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

• 9.1. Introduction
• 9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 9.3.1. By Country
    • 9.3.1.1. U.S.
    • 9.3.1.2. Canada
  • 9.3.2. By Product Type
  • 9.3.3. By End User
• 9.4. Market Attractiveness Analysis
• 9.5. Drivers & Restraints: Impact Analysis

10. Latin America Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 10.3.1. By Country
    • 10.3.1.1. Brazil
    • 10.3.1.2. Mexico
    • 10.3.1.3. Rest of Latin America
  • 10.3.2. By Product Type
  • 10.3.3. By End User
• 10.4. Market Attractiveness Analysis
• 10.5. Drivers & Restraints: Impact Analysis

11. Europe Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 11.3.1. By Country
    • 11.3.1.1. Germany
    • 11.3.1.2. U.K.
    • 11.3.1.3. France
    • 11.3.1.4. Italy
    • 11.3.1.5. Spain
    • 11.3.1.6. Poland
    • 11.3.1.7. Russia
    • 11.3.1.8. Rest of Europe
  • 11.3.2. By Product Type
  • 11.3.3. By End User
• 11.4. Market Attractiveness Analysis
• 11.5. Drivers & Restraints: Impact Analysis

12. Asia-Pacific Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 12.3.1. By Country
    • 12.3.1.1. China
    • 12.3.1.2. India
    • 12.3.1.3. Japan
    • 12.3.1.4. Australia & New Zealand
    • 12.3.1.5. Rest of Asia-Pacific
  • 12.3.2. By Product Type
  • 12.3.3. By End User
• 12.4. Market Attractiveness Analysis
• 12.5. Drivers & Restraints: Impact Analysis

13. Middle East and Africa Orthopedic Veterinary Implants Market Analysis 2019-2023 and Forecast 2024-2031

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2031
  • 13.3.1. By Country
    • 13.3.1.1. GCC Countries
    • 13.3.1.2. South Africa
    • 13.3.1.3. Rest of MEA
  • 13.3.2. By Product Type
  • 13.3.3. By End User
• 13.4. Market Attractiveness Analysis
• 13.5. Drivers & Restraints: Impact Analysis

14. Competition Analysis

• 14.1. Competition Dashboard
• 14.2. Competition Deep Dive
  • 14.2.1. Vet Implants
    • 14.2.1.1. Company Overview
    • 14.2.1.2. Segment Overview
    • 14.2.1.3. Product Offerings
    • 14.2.1.4. Financial Analysis
    • 14.2.1.5. Key Developments
    • 14.2.1.6. Strategy Overview
  • 14.2.2. scil animal care company GmbH
    • 14.2.2.1. Company Overview
    • 14.2.2.2. Segment Overview
    • 14.2.2.3. Product Offerings
    • 14.2.2.4. Financial Analysis
    • 14.2.2.5. Key Developments
    • 14.2.2.6. Strategy Overview
  • 14.2.3. KYON Pharma, Inc.
    • 14.2.3.1. Company Overview
    • 14.2.3.2. Segment Overview
    • 14.2.3.3. Product Offerings
    • 14.2.3.4. Financial Analysis
    • 14.2.3.5. Key Developments
    • 14.2.3.6. Strategy Overview
  • 14.2.4. Everost Inc.
    • 14.2.4.1. Company Overview
    • 14.2.4.2. Segment Overview
    • 14.2.4.3. Product Offerings
    • 14.2.4.4. Financial Analysis
    • 14.2.4.5. Key Developments
    • 14.2.4.6. Strategy Overview
  • 14.2.5. BioMedtrix, LLC
    • 14.2.5.1. Company Overview
    • 14.2.5.2. Segment Overview
    • 14.2.5.3. Product Offerings
    • 14.2.5.4. Financial Analysis
    • 14.2.5.5. Key Developments
    • 14.2.5.6. Strategy Overview
  • 14.2.6. Integra LifeSciences
    • 14.2.6.1. Company Overview
    • 14.2.6.2. Segment Overview
    • 14.2.6.3. Product Offerings
    • 14.2.6.4. Financial Analysis
    • 14.2.6.5. Key Developments
    • 14.2.6.6. Strategy Overview
  • 14.2.7. RITA LEIBINGER MEDICAL GmbH & Co. KG
    • 14.2.7.1. Company Overview
    • 14.2.7.2. Segment Overview
    • 14.2.7.3. Product Offerings
    • 14.2.7.4. Financial Analysis
    • 14.2.7.5. Key Developments
    • 14.2.7.6. Strategy Overview
  • 14.2.8. B. Braun Melsungen AG
    • 14.2.8.1. Company Overview
    • 14.2.8.2. Segment Overview
    • 14.2.8.3. Product Offerings
    • 14.2.8.4. Financial Analysis
    • 14.2.8.5. Key Developments
    • 14.2.8.6. Strategy Overview
  • 14.2.9. DePuy Synthes (Sub. Johnson & Johnson Services, Inc.)
    • 14.2.9.1. Company Overview
    • 14.2.9.2. Segment Overview
    • 14.2.9.3. Product Offerings
    • 14.2.9.4. Financial Analysis
    • 14.2.9.5. Key Developments
    • 14.2.9.6. Strategy Overview
  • 14.2.10. Intrauma S.p.A.
    • 14.2.10.1. Company Overview
    • 14.2.10.2. Segment Overview
    • 14.2.10.3. Product Offerings
    • 14.2.10.4. Financial Analysis
    • 14.2.10.5. Key Developments
    • 14.2.10.6. Strategy Overview
  • 14.2.11. Surgical Holdings
    • 14.2.11.1. Company Overview
    • 14.2.11.2. Segment Overview
    • 14.2.11.3. Product Offerings
    • 14.2.11.4. Financial Analysis
    • 14.2.11.5. Key Developments
    • 14.2.11.6. Strategy Overview
  • 14.2.12. Ortho Max Manufacturing Company Pvt. Ltd. Novartis AG
    • 14.2.12.1. Company Overview
    • 14.2.12.2. Segment Overview
    • 14.2.12.3. Product Offerings
    • 14.2.12.4. Financial Analysis
    • 14.2.12.5. Key Developments
    • 14.2.12.6. Strategy Overview

15. Assumptions and Acronyms Used

16. Research Methodology